4
Changes in Ownership
Editas Medicine, Inc. Filed Acc 0001179110-19-001682
Options or other derivatives
- Chief Technology Officer acquired 56,875 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Myer Vickesh Chief Technology Officer | 2019-02-06 | Grant or award · Stock Option (right to buy) | +48,750 | 48,750 | D: show line 1 in the form | |||||
| Myer Vickesh Chief Technology Officer | 2019-02-06 | Grant or award · Restricted Stock Units | +8,125 | 8,125 | D: show line 2 in the form |
Loading xslF345X03/edgar.xml…